UK to address surgery cancellations
This article was originally published in Clinica
"There is no room for complacency." This is how the UK's Department of Health underlined its commitment to tackle surgery cancellations, in light of data released today. In England, during the period July-September (Q2 2006-07), 12,275 operations (0.8% of all elective surgery) were cancelled at the last minute for non-clinical reasons, a small improvement on the 13,058 of Q2 2005-06. Delays in re-arranging the operation, although significantly better than a year ago, remain a source of concern: 637 (5.2%) cases were not treated within 28 days; last year, the figure was 1,160 (8.9%). At the end of October 2006, the number of patients waiting in England over 13 weeks for an operation stood at 188,300, down 2.3% from September and 9.4% since October 2005. The NHS performs 662,000 more operations per year now than in 1997, the DoH notes.
You may also be interested in...
Private Company Edition: While venture capital invested in the industry dropped in 2019, the number of deals rose as investors funded more early-stage VC rounds. Money continues flowing to large deals as well, including $105m for ALX Oncology and $98m for CANbridge.
Roughly 18.5% of patients who received reinterventions to fix mesh implants for pelvic organ prolapse (POP) repair experienced complications they will likely endure for the rest of their lives, and they also face a 2.5% higher rate of further surgeries than non-mesh patients, says a recent 54,194-woman study detailed in Obstetrics & Gynecology. The study authors lay out a case that the US FDA should have forced removal of mesh from the market sooner.
HAL Allergy Group, developer of products for allergy diagnostics and allergen immunotherapy, promoted its principal scientist to chief R&D officer; Starkey Hearing Technologies brought on new health and business development execs to expand its global footprint; and more.